109 - HIV State of the Art: On the Horizon

Moderator(s)

• 

  Jose Castillo-Mancilla, MD

  Associate Professor of Medicine
  University of Colorado, CO, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KT

  Karen Tashima, MD

  Professor of Medicine
  Warren Alpert Medical School of Brown University
  Providence, RI, United States

  Gilead Sciences Inc. (Individual(s) Involved: Self): Scientific Research Study Investigator; Viiv Healthcare (Individual(s) Involved: Self): Research Grant or Support

Speaker(s)

• 

  Eileen Scully, MD, PhD

  Assistant Professor of Medicine
  Johns Hopkins University School of Medicine
  Baltimore, MD, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Latesha Elopre, MD

  Assistant Professor of Medicines
  University of Alabama
  Birmingham, AL, United States

  Merck/MSD (Individual(s) Involved: Self): Grant/Research Support, Phase III Clinical Trial for long-acting PrEP among cis-gender women.
• 

  Cecile Lahiri, MD, MS

  Associate Professor
  Emory University
  Atlanta, GA, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Presentations:

• Gender Differences in Inflammation and Disease Progression
  

  Speaker: Eileen P. Scully, MD, PhD – Johns Hopkins University
• Gender Differences in PrEP Efficacy and Uptake
  

  Speaker: Latesha Elopre, MD – University of Alabama
• Sex and Gender Differences in Comorbidities in HIV
  

  Speaker: Cecile D. Lahiri, MD, MS – Emory University